CXI Healthcare Technology Group Limited (KOSDAQ: 900120)
South Korea
· Delayed Price · Currency is KRW
67.00
-1.00 (-1.47%)
Dec 20, 2024, 9:00 AM KST
CXI Healthcare Technology Group Cash Flow Statement
Financials in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Net Income | 28,599 | 29,349 | 7,528 | 5,981 | 5,098 | -98,437 | Upgrade
|
Depreciation & Amortization | 24,238 | 24,642 | 23,980 | 25,713 | 18,669 | 13,956 | Upgrade
|
Loss (Gain) From Sale of Assets | -3,823 | -3,823 | - | 509.09 | - | 12.21 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 153.75 | - | - | 40,369 | Upgrade
|
Loss (Gain) From Sale of Investments | -6,798 | -6,798 | - | - | - | - | Upgrade
|
Loss (Gain) on Equity Investments | -432.13 | -295.04 | -224.74 | - | - | - | Upgrade
|
Stock-Based Compensation | - | - | -54.43 | 660.98 | 412.3 | - | Upgrade
|
Other Operating Activities | 679.71 | 1,070 | -631.65 | 120.48 | -377.99 | -1,780 | Upgrade
|
Change in Accounts Receivable | 2,791 | -559.33 | 6,212 | 6,139 | -24,131 | 18,499 | Upgrade
|
Change in Inventory | 62.27 | 71.79 | 170.95 | 1,145 | 766.74 | -355.32 | Upgrade
|
Change in Accounts Payable | -251.04 | 11.07 | -4,396 | -4,352 | 4,655 | -12,928 | Upgrade
|
Change in Other Net Operating Assets | 282.37 | -3.89 | -1,141 | 67.31 | 3,631 | -3,658 | Upgrade
|
Operating Cash Flow | 45,349 | 43,666 | 31,597 | 35,984 | 8,723 | -44,322 | Upgrade
|
Operating Cash Flow Growth | 27.26% | 38.19% | -12.19% | 312.50% | - | - | Upgrade
|
Capital Expenditures | - | - | - | -5.78 | -204,888 | -65,700 | Upgrade
|
Sale of Property, Plant & Equipment | 16,255 | 16,255 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | - | - | -0.49 | - | Upgrade
|
Investment in Securities | - | - | -228.52 | - | - | 152,694 | Upgrade
|
Other Investing Activities | 268.27 | 256.26 | 202.93 | 146.23 | 330.28 | 1,861 | Upgrade
|
Investing Cash Flow | 16,523 | 16,511 | -25.3 | 140.45 | -204,558 | 88,855 | Upgrade
|
Short-Term Debt Issued | - | - | 234.78 | - | - | - | Upgrade
|
Long-Term Debt Issued | - | 65.65 | 326.24 | 124.63 | 854 | 809.17 | Upgrade
|
Total Debt Issued | 179.33 | 65.65 | 561.02 | 124.63 | 854 | 809.17 | Upgrade
|
Short-Term Debt Repaid | - | -204.26 | -45.33 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -668.42 | -18.27 | -36.31 | -108.57 | -108.29 | Upgrade
|
Total Debt Repaid | -871.74 | -872.67 | -63.6 | -36.31 | -108.57 | -108.29 | Upgrade
|
Net Debt Issued (Repaid) | -692.42 | -807.03 | 497.42 | 88.33 | 745.43 | 700.88 | Upgrade
|
Issuance of Common Stock | - | - | 961.72 | 1,072 | - | - | Upgrade
|
Other Financing Activities | 9.53 | 1,060 | -2.73 | -4.87 | -2.65 | -6.81 | Upgrade
|
Financing Cash Flow | -682.89 | 252.81 | 1,456 | 1,156 | 742.78 | 694.07 | Upgrade
|
Foreign Exchange Rate Adjustments | -1.29 | -43.61 | -129.59 | -21.14 | -1.24 | -15.97 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | - | 0 | 0 | - | 0 | Upgrade
|
Net Cash Flow | 61,188 | 60,386 | 32,899 | 37,260 | -195,093 | 45,211 | Upgrade
|
Free Cash Flow | 45,349 | 43,666 | 31,597 | 35,979 | -196,165 | -110,022 | Upgrade
|
Free Cash Flow Growth | 27.26% | 38.19% | -12.18% | - | - | - | Upgrade
|
Free Cash Flow Margin | 67.27% | 62.90% | 44.12% | 35.49% | -187.55% | -173.52% | Upgrade
|
Free Cash Flow Per Share | 164.80 | 173.09 | 257.67 | 293.40 | -1763.18 | -996.54 | Upgrade
|
Cash Interest Paid | 4.76 | 5.24 | 2.73 | 4.87 | 2.65 | 6.81 | Upgrade
|
Levered Free Cash Flow | 37,861 | 35,741 | 29,692 | 30,374 | -198,312 | -76,690 | Upgrade
|
Unlevered Free Cash Flow | 37,864 | 35,744 | 29,694 | 30,407 | -198,301 | -76,685 | Upgrade
|
Change in Net Working Capital | -2,608 | 556.71 | -1,311 | -130.53 | 15,317 | -13,777 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.